INAB IN8bio, Inc. - Common Stock
$1,16
Harga · Agu 18, 2026
Fundamental per Agu 6, 2026
Rentang 52M
$1–$3
15% of range
Peringkat Analis
BUY
10 analysts
Target Harga
$6
+439% upside
P/E (TTM)
-0.3
ROE
-90.8%
Margin Laba Bersih
—
INAB Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$1.16
Kapitalisasi Pasar
$11M
P/E (TTM)
-0.3
EPS (TTM)
$-4.44
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
-90.8%
D/E Utang/Ekuitas
—
Rentang 52M
$1 – $3
INAB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
$-4.44
2021-12-31
→
2025-12-31
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
INAB
Median Rekan
P/E (TTM)
-0.3
—
P/B
0.4
0.9
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
INAB
Median Rekan
ROA
-73.0%
-74.6%
ROE
-90.8%
-92.1%
ROIC
-70.5%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
INAB
Median Rekan
Current Ratio (Rasio Lancar)
8.8
2.7
Quick Ratio (Rasio Cepat)
8.6
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
INAB
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
INAB
Median Rekan
INAB Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
10 analis
- Beli Kuat 2 20,0%
- Beli 7 70,0%
- Tahan 1 10,0%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
4 analis · 2026-08-19
Median
$5.50
Rata-rata
$6.25
← Di bawah semua target
$1.16
Rendah
$4.00
Tinggi
$10.00
Target median
$5.50
+374,2%
Target rata-rata
$6.25
+438,8%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.28%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.25 | $-0.38 | 0.13% |
| 31 Maret 2026 | $-0.26 | $-0.70 | 0.44% |
| 31 Des. 2025 | $-0.45 | $-0.63 | 0.18% |
| 30 Sep. 2025 | $-0.85 | $-1.25 | 0.40% |
| 30 Juni 2025 | $-1.24 | $-1.84 | 0.60% |
| 31 Maret 2025 | $-2.10 | $-2.04 | -0.06% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| INAB | $23M | -0.5 | — | — | -90.8% | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
| OSRH | — | — | — | — | — | — |
| LSTA | — | -1.0 | -83.0% | — | — | — |
| BIVI | — | — | — | — | — | — |
| LNAI | $513M | -2.7 | — | — | -586.4% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 13
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $17M | $17M | $14M | $7M | $5M | |
| SG&A Expense | $10M | $13M | $14M | $14M | $7M | $3M | |
| Operating Expenses | $20M | $31M | $30M | $29M | $15M | $9M | |
| Operating Income | $-19M | $-30M | $-30M | $-29M | $-15M | $-9M | |
| Interest Income | $421.0K | $230.0K | $0 | · | · | · | |
| Pretax Income | $-19M | $-31M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $-30M | $-30M | $-29M | $-15M | $-9M | |
| EPS (Basic) | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 | · | |
| EPS (Diluted) | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 | · | |
| Shares (Basic) | 4,374,328 | 1,784,890 | 29,864,932 | 20,967,955 | 9,969,733 | · | |
| Shares (Diluted) | 4,374,328 | 1,784,890 | 29,864,932 | 20,967,955 | 9,969,733 | · | |
| EBITDA | $-19M | · | $-30M | $-29M | $-15M | · |
Neraca 20
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $11M | $21M | $18M | $37M | $18M | |
| Prepaid Expense | $788.0K | $1M | $3M | $4M | $2M | $150.0K | |
| Other Current Assets | $259.0K | $298.0K | $270.0K | $232.0K | $52.0K | $0 | |
| Current Assets | $28M | $13M | $25M | $22M | $39M | $18M | |
| PP&E (Net) | $2M | $3M | $4M | $4M | $97.0K | $186.0K | |
| PP&E (Gross) | · | · | · | · | $443.0K | $443.0K | |
| Accum. Depreciation | $3M | $2M | $1M | $321.0K | $346.0K | $257.0K | |
| Other Non-current Assets | $146.0K | $275.0K | $255.0K | $255.0K | $158.0K | $0 | |
| Total Assets | $32M | $21M | $34M | $33M | $42M | $21M | |
| Accounts Payable | $309.0K | $389.0K | $924.0K | $2M | $395.0K | $620.0K | |
| Accrued Liabilities | $2M | $1M | $3M | $2M | $1M | $2M | |
| Current Liabilities | $3M | $3M | $5M | $6M | $2M | $3M | |
| Capital Leases | $2M | $3M | $3M | $4M | $2M | $0 | |
| Total Liabilities | $5M | $6M | $9M | $10M | $4M | $3M | |
| Common Stock | $10.0K | $7.0K | $4.0K | $3.0K | $2.0K | $1.0K | |
| Paid-in Capital | $169M | $136M | $116M | $84M | $71M | $1M | |
| Retained Earnings | $-141M | $-122M | $-91M | $-61M | $-33M | $-18M | |
| Stockholders' Equity | $28M | $14M | $25M | $23M | $-38M | $-17M | |
| Liabilities + Equity | $32M | $21M | $34M | $33M | $42M | $21M | |
| Shares Outstanding | 9,766,132 | 2,416,066 | 43,287,325 | 24,545,157 | 18,781,242 | 3,764,488 |
Arus Kas 8
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $5M | $4M | $3M | $2M | $357.0K | |
| Deferred Tax | $-2M | $-6M | $-6M | $-5M | $-5M | $-3M | |
| Operating Cash Flow | $-13M | $-24M | $-23M | $-24M | $-14M | $-7M | |
| Investing Cash Flow | $0 | $-187.0K | $-600.0K | $-4M | $-309.0K | $0 | |
| Stock Issued | $9M | $4M | $14M | $10M | $36M | $499.0K | |
| Net Stock Activity | $9M | · | $14M | $10M | $36M | · | |
| Financing Cash Flow | $29M | $14M | $27M | $9M | $33M | $25M | |
| Net Change in Cash | $16M | $-10M | $3M | $-19M | $19M | $17M |
Profitabilitas 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -73.0% | · | -89.9% | -75.8% | -46.4% | · | |
| ROE | -90.8% | · | -140.6% | -109.1% | -36.1% | · | |
| ROIC | -70.5% | · | · | · | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.8 | · | 4.6 | 3.8 | 17.3 | · | |
| Quick Ratio | 8.6 | · | 3.9 | 3.1 | 16.4 | · |
Valuasi (TTM) 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-30M | $-30M | $-29M | $-15M | · | |
| Market Cap | $23M | · | $1.79B | $1.70B | $2.47B | · | |
| P/E | -0.5 | -0.5 | -41.4 | -51.0 | -89.6 | · | |
| P/B | 0.8 | · | 71.9 | 74.8 | 64.8 | · | |
| P / Tangible Book | 0.8 | 38.6 | 71.9 | 74.8 | · | · | |
| P / Cash Flow | -1.8 | · | -76.8 | -70.5 | -183.1 | · | |
| Earnings Yield | -189.7% | -221.1% | -2.4% | -2.0% | -1.1% | · |
Laporan Laba Rugi 11
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $3M | $2M | $2M | $3M | $4M | $3M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| SG&A Expense | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $4M | $3M | |
| Operating Expenses | $5M | $5M | $5M | $4M | $5M | $6M | $6M | $7M | $9M | $9M | $8M | $7M | $8M | $8M | $8M | $7M | |
| Operating Income | $-5M | $-5M | $-5M | $-4M | $-5M | $-6M | $-6M | $-7M | $-9M | $-9M | $-8M | $-7M | $-8M | $-8M | $-8M | $-7M | |
| Interest Income | $154.0K | $176.0K | $91.0K | $113.0K | $107.0K | $110.0K | $64.0K | $23.0K | $60.0K | $83.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-5M | $-5M | $-5M | $-4M | $-5M | $-6M | $-6M | $-7M | $-9M | $-9M | $-8M | $-7M | $-8M | $-8M | $-8M | $-7M | |
| EPS (Basic) | $-0.25 | $-0.26 | $-2.28 | $-0.85 | $-1.24 | $-2.16 | $-6.85 | $-4.49 | $-5.51 | $-0.20 | $-0.20 | $-0.23 | $-0.27 | $-0.30 | $-0.31 | $-0.34 | |
| EPS (Diluted) | $-0.25 | $-0.26 | $-2.28 | $-0.85 | $-1.24 | $-2.16 | $-6.85 | $-4.49 | $-5.51 | $-0.20 | $-0.20 | $-0.23 | $-0.27 | $-0.30 | $-0.31 | $-0.34 | |
| Shares (Basic) | 19,467,091 | 19,467,114 | -87,764,633 | 4,537,683 | 4,119,153 | 2,575,325 | -44,646,749 | 1,577,363 | 1,566,951 | 43,287,325 | -54,885,777 | 31,545,783 | 28,472,346 | 24,732,580 | -38,322,815 | 21,661,544 | |
| Shares (Diluted) | 19,467,091 | 19,467,114 | -87,764,633 | 4,537,683 | 4,119,153 | 2,575,325 | -44,646,749 | 1,577,363 | 1,566,951 | 43,287,325 | -54,885,777 | 31,545,783 | 28,472,346 | 24,732,580 | -38,322,815 | 21,661,544 | |
| EBITDA | $-5M | $-5M | · | $-4M | $-5M | $-6M | · | $-7M | $-9M | $-9M | · | $-7M | $-8M | $-8M | · | $-7M |
Neraca 19
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $22M | $27M | $11M | $13M | $12M | $11M | $4M | $10M | $13M | $21M | $13M | $17M | $11M | $18M | $28M | |
| Prepaid Expense | $540.0K | $721.0K | $788.0K | $1M | $515.0K | $837.0K | $1M | $3M | $2M | $3M | $3M | $4M | $2M | $4M | $4M | $2M | |
| Other Current Assets | $364.0K | $395.0K | $259.0K | $346.0K | $367.0K | $427.0K | $298.0K | $177.0K | $529.0K | $539.0K | $270.0K | $262.0K | $277.0K | $601.0K | $232.0K | · | |
| Current Assets | $18M | $23M | $28M | $12M | $14M | $13M | $13M | $7M | $13M | · | $25M | $17M | $19M | $14M | $22M | $30M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $350.0K | |
| Accum. Depreciation | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $807.0K | $564.0K | $321.0K | $417.0K | |
| Other Non-current Assets | $102.0K | $129.0K | $146.0K | $169.0K | $275.0K | $275.0K | $275.0K | $324.0K | $320.0K | · | $255.0K | $255.0K | $255.0K | $255.0K | $255.0K | $231.0K | |
| Total Assets | $22M | $26M | $32M | $17M | $19M | $20M | $21M | $16M | $22M | · | $34M | $26M | $30M | $25M | $33M | $38M | |
| Accounts Payable | $444.0K | $449.0K | $309.0K | $204.0K | $379.0K | $575.0K | $389.0K | $1M | $1M | · | $924.0K | $748.0K | $585.0K | $870.0K | $2M | $1M | |
| Accrued Liabilities | $761.0K | $681.0K | $2M | $418.0K | $635.0K | $1M | $1M | $769.0K | $2M | $895.0K | $3M | $2M | $2M | $1M | $2M | $3M | |
| Current Liabilities | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $5M | · | $5M | $5M | $4M | $4M | $6M | $5M | |
| Capital Leases | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | |
| Total Liabilities | $3M | $3M | $5M | $4M | $4M | $6M | $6M | $7M | $9M | · | $9M | $8M | $8M | $8M | $10M | $9M | |
| Common Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $7.0K | $5.0K | $5.0K | · | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $169M | $169M | $169M | $149M | $148M | $141M | $136M | $124M | $122M | · | $116M | $101M | $98M | $86M | $84M | $83M | |
| Retained Earnings | $-151M | $-146M | $-141M | $-136M | $-132M | $-127M | $-122M | $-115M | $-108M | · | $-91M | $-84M | $-76M | $-69M | $-61M | $-53M | |
| Stockholders' Equity | $18M | $23M | $28M | $13M | $15M | $14M | $14M | $9M | $14M | $18M | $25M | $18M | $22M | $17M | $23M | $30M | |
| Liabilities + Equity | $22M | $26M | $32M | $17M | $19M | $20M | $21M | $16M | $22M | · | $34M | $26M | $30M | $25M | $33M | $38M | |
| Shares Outstanding | 9,853,121 | 9,847,089 | 9,766,132 | 4,589,196 | 4,078,139 | 81,258,763 | 2,416,066 | 46,786,948 | 46,434,656 | · | 43,287,325 | 31,975,929 | 30,606,119 | 24,960,869 | 24,545,157 | 24,502,157 |
Arus Kas 9
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $352.0K | $401.0K | $711.0K | $692.0K | $955.0K | $831.0K | $825.0K | $2M | $1M | $1M | $1M | $1M | $1M | $859.0K | $922.0K | $897.0K | |
| Operating Cash Flow | $-4M | $-5M | $-2M | $-4M | $-4M | $-3M | $-4M | $-6M | $-6M | $-8M | $-5M | $-6M | $-5M | $-7M | $-8M | $-6M | |
| CapEx | · | · | · | $0 | $0 | $0 | · | $0 | $21.0K | $50.0K | · | $0 | $36.0K | $371.0K | · | $39.0K | |
| Investing Cash Flow | $-233.0K | $-9.0K | $0 | $0 | $0 | $0 | $-33.0K | $0 | $-83.0K | $-71.0K | $-72.0K | $-77.0K | $-22.0K | $-429.0K | $-1M | $-2M | |
| Stock Issued | $0 | $0 | $102.0K | $1M | $4M | $4M | $4M | $-4M | $4M | $0 | $63.0K | $2M | $12M | $722.0K | $9M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $4M | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-51.0K | $-195.0K | $18M | $989.0K | $5M | $4M | $11M | $-105.0K | $3M | $-277.0K | $13M | $2M | $11M | $547.0K | $-253.0K | $9M | |
| Net Change in Cash | $-4M | $-5M | $16M | $-3M | $1M | $771.0K | $7M | $-6M | $-3M | $-8M | $8M | $-4M | $6M | $-7M | $-9M | $2M | |
| Free Cash Flow | · | · | · | · | · | $-3M | · | · | · | $-8M | · | · | · | $-8M | · | · |
Profitabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -23.3% | -22.1% | · | -23.5% | -24.3% | -24.9% | · | -33.6% | -33.1% | · | · | -22.2% | -25.4% | -24.6% | · | -17.3% | |
| ROE | -28.5% | -27.8% | · | -35.4% | -35.3% | -35.4% | · | -53.8% | -48.7% | -49.9% | · | -30.3% | -31.9% | -30.3% | · | -20.4% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.2 | 10.5 | · | 6.9 | 7.0 | 4.3 | · | 1.8 | 2.7 | · | · | 3.5 | 5.1 | 3.8 | · | 6.1 | |
| Quick Ratio | 8.0 | 10.2 | · | 6.3 | 6.8 | 4.0 | · | 1.1 | 2.1 | · | · | 2.7 | 4.5 | 2.9 | · | 5.6 |
Valuasi (TTM) 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-20M | · | $-22M | $-26M | $-30M | · | $-31M | $-32M | $-31M | · | $-30M | $-30M | $-28M | · | $-24M | |
| Market Cap | $14M | $15M | · | $10M | $9M | $405M | · | $379M | $1.18B | · | · | $998M | $1.41B | $973M | · | $1.48B | |
| P/E | -0.5 | -0.3 | · | -0.3 | -0.2 | -0.5 | · | -0.8 | -4.1 | -35.4 | · | -27.4 | -35.8 | -28.9 | · | -46.6 | |
| P/B | 0.8 | 0.6 | · | 0.8 | 0.6 | 29.2 | · | 44.1 | 86.6 | · | · | 56.2 | 64.9 | 58.0 | · | 50.2 | |
| P / Tangible Book | 0.8 | 0.6 | · | 0.8 | 0.6 | 29.2 | · | 44.1 | 86.6 | · | · | 56.2 | 64.9 | 58.0 | · | 50.2 | |
| P / Cash Flow | · | -2.9 | · | · | · | -129.6 | · | · | · | · | · | · | · | -130.9 | · | · | |
| P / FCF | · | · | · | · | · | -129.6 | · | · | · | · | · | · | · | -124.6 | · | · | |
| Earnings Yield | -184.4% | -304.7% | · | -306.4% | -541.1% | -206.2% | · | -128.8% | -24.4% | -2.8% | · | -3.6% | -2.8% | -3.5% | · | -2.1% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Laba Bersih | $-19M | $-30M | $-30M | $-29M | $-15M |
| EPS Dilusian | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 8.8 | — | 4.6 | 3.8 | 17.3 |
| Rasio Cepat | 8.6 | — | 3.9 | 3.1 | 16.4 |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 23 pengaju · $5.4M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 3 (-1 vs Kuartal sebelumnya) | 1 (-3 vs Kuartal sebelumnya) | 5 (+3 vs Kuartal sebelumnya) | 1 (-4 vs Kuartal sebelumnya) | +130K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | $1.331.490 | 944.319 | 24,50% | Saham |
| FRANKLIN RESOURCES INC | $1.289.489 | 914.531 | 23,73% | Saham |
| 683 Capital Management, LLC | $1.021.738 | 724.637 | 18,80% | Saham |
| Stonepine Capital Management, LLC | $980.355 | 695.287 | 18,04% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $126.544 | 88.865 | 2,33% | Saham |
| BIOS Capital Management, LP | $114.149 | 80.957 | 2,10% | Saham |
| CITADEL ADVISORS LLC | $88.908 | 63.055 | 1,64% | Saham |
| OPPENHEIMER & CO INC | $88.889 | 63.042 | 1,64% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $85.677 | 60.762 | 1,58% | Saham |
| TWO SIGMA ADVISERS, LP | $85.061 | 36.351 | 1,57% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $62.044 | 43.570 | 1,14% | Saham |
| CAPTRUST FINANCIAL ADVISORS | $46.946 | 33.295 | 0,86% | Saham |
| Texas Capital Bank Wealth Management Services Inc | $34.412 | 24.406 | 0,63% | Saham |
| NORTHERN TRUST CORP | $30.645 | 21.734 | 0,56% | Saham |
| VANGUARD GROUP INC | $20.763 | 8.873 | 0,38% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $17.061 | 12.100 | 0,31% | Saham |
| Tower Research Capital LLC (TRC) | $5.271 | 3.738 | 0,10% | Saham |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $3.927 | 2.785 | 0,07% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $1.044 | 768 | 0,02% | Saham |
| BlackRock, Inc. | $118 | 84 | 0,00% | Saham |
| Rockefeller Capital Management L.P. | $117 | 83 | 0,00% | Saham |
| BARCLAYS PLC | $39 | 28 | 0,00% | Saham |
| UBS Group AG | $1 | 1 | 0,00% | Saham |
Orang dalam perusahaan 12 orang dalam · 5 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| William Tai-Wei Ho | President and CEO | 13 Des. 2023 A | 2.421.512 | 0 | 0 | $0 |
| McCall Patrick | Chief Financial Officer | 13 Des. 2023 A | 26.755 | 0 | 0 | $0 |
| Kate Rochlin | Chief Operating Officer | 13 Des. 2023 A | 17.558 | 0 | 0 | $0 |
| Trishna Goswami | Chief Medical Officer | 13 Des. 2023 A | 6.729 | 0 | 0 | $0 |
| Lawrence Lamb | EVP and CSO | 13 Des. 2023 A | 101.369 | 0 | 0 | $0 |
| Jeremy R. Graff | Direktur | 13 Des. 2023 A | 4.549 | 0 | 0 | $0 |
| Corinne Epperly | Direktur | 13 Des. 2023 A | 81.967 | 0 | 0 | $0 |
| Alan S. Roemer | Direktur | 13 Des. 2023 A | 158.448 | 0 | 0 | $0 |
| Peter C. Brandt | Direktur | 13 Des. 2023 A | 264.440 | 0 | 0 | $0 |
| EMILY FAIRBAIRN | Direktur | 28 Juli 2023 J | 0 | 0 | 0 | $0 |
| Luba Greenwood | Direktur | 15 Juni 2023 A | 7.826 | 0 | 0 | $0 |
| Travis Whitfill | Direktur | 15 Juni 2023 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| EMILY FAIRBAIRN, Malcom Fairbairn, Malcom and Emily Fairbairn 2010 CRUT ×2 pengajuan | 29 Mei 2026 | 2,20% | Amandemen | — | SEC |
| BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III QP, LP, BIOS Fund III NT, LP, Bios Clinical Opportunity Fund, LP, BP Directors, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Bios Equity COF, LP, Cavu Management, LP, BIOS Capital Management, LP, Cavu Advisors, LLC, BIOS Advisors GP, LLC, Kreis Leslie W., Fletcher Aaron G.L. ×5 pengajuan | 29 Des. 2025 | 2,90% | Amandemen | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 2 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.